Fatostatin
Based on 53 publication(s) in Google Scholar
Fatostatin (125B11), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin decreases the transcription of lipogenic genes in cells. Fatostatin possesses antitumor properties, and lowers hyperglycemia in ob/ob mice.
For research use only. We do not sell to patients.
- Purity: 99.85%
- CAS No.: 125256-00-0
- Formula: C18H18N2S
- Molecular Weight:294.41
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Fatostatin
More- Nature. 2026 Apr;652(8108):209-219. [Abstract]
- Cancer Cell. 2024 Sep 26:S1535-6108(24)00350-7. [Abstract]
- Cell Metab. 2021 Aug 3;33(8):1655-1670.e8. [Abstract]
- Cell Mol Immunol. 2025 Oct 29. [Abstract]
- Nat Commun. 2026 Jan 20;17(1):614. [Abstract]
- Nat Commun. 2025 Feb 25;16(1):1774. [Abstract]
- Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]
- Cell Death Differ. 2021 Jun;28(6):2001-2018. [Abstract]
- Autophagy. 2021 Jul;17(7):1592-1613. [Abstract]
- Adv Sci (Weinh). 2025 Apr 24:e2407671. [Abstract]
- J Clin Invest. 2025 Jul 8:e193134. [Abstract]
- J Exp Clin Cancer Res. 2019 May 29;38(1):228. [Abstract]
- Cell Mol Biol Lett. 2024 Aug 21;29(1):112. [Abstract]
- Cancer Lett. 2024 Jun 18:217068. [Abstract]
- Cell Death Dis. 2026 Jan 7;17(1):5. [Abstract]
- Cell Death Dis. 2025 May 16;16(1):391. [Abstract]
- Cell Death Dis. 2024 Jun 12;15(6):411. [Abstract]
- Cell Death Dis. 2021 May 26;12(6):544. [Abstract]
- Cancer Immunol Res. 2025 Dec 9. [Abstract]
- Free Radic Biol Med. 2025 Aug 19:240:170-182. [Abstract]
- NPJ Precis Oncol. 2024 Mar 1;8(1):58. [Abstract]
- Emerg Microbes Infect. 2025 Dec;14(1):2470371. [Abstract]
- Cell Death Discov. 2022 Oct 28;8(1):431. [Abstract]
- Cell Rep. 2025 Feb 19;44(3):115339. [Abstract]
- Cell Rep. 2022 Nov 29;41(9):111738. [Abstract]
- Mol Med. 2024 Feb 21;30(1):28. [Abstract]
- Cell Mol Life Sci. 2025 Jul 3;82(1):270. [Abstract]
- Cell Mol Life Sci. 2024 Jul 6;81(1):289. [Abstract]
- Cell Biosci. 2023 Oct 3;13(1):186. [Abstract]
- JCI Insight. 2024 Jun 18:e180132. [Abstract]
- J Ethnopharmacol. 2026 Feb 28:357:120890. [Abstract]
- J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117162. [Abstract]
- J Pathol. 2020 Dec;252(4):358-370. [Abstract]
- Eur J Pharmacol. 2025 Sep 15:1003:177890. [Abstract]
- Int Immunopharmacol. 2024 Jul 18:139:112669. [Abstract]
- Mol Oncol. 2025 Jun;19(6):1668-1686. [Abstract]
- Cancers (Basel). 2023 Jun 3;15(11):3043. [Abstract]
- J Cell Mol Med. 2025 Jul;29(14):e70710. [Abstract]
- iScience. 2024 Jun 29;27(8):110424. [Abstract]
- Oncol Rep. 2018 Apr;39(4):1919-1929. [Abstract]
- Biochim Biophys Acta Mol Cell Biol Lipids. 2025 Jun 6:159642. [Abstract]
- Mol Carcinog. 2023 Jul;62(7):963-974. [Abstract]
- Br J Nutr. 2024 Feb 28;131(4):553-566. [Abstract]
- Anal Cell Pathol. 2026;2026(1):e6120748. [Abstract]
- Exp Eye Res. 2026 May:266:110932. [Abstract]
- Exp Eye Res. 2025 Jan 10:110239. [Abstract]
- Tissue Cell. 2025 Sep 9:98:103134. [Abstract]
- Oncol Lett. 2020 Sep;20(3):2855-2869. [Abstract]
- Biol Pharm Bull. 2022 Apr 1;45(4):438-445. [Abstract]
- Res Sq. 2026 Jun 15.
- University of Tubingen. 2025.
- Res Sq. 2024 Nov 18.
- Research Square Preprint. 2022 May.
-
Cell Proliferation/Viability Assay
-
2D/3D Cell Culture and Differentiation
-
WB
-
WB
-
Cell Proliferation/Viability Assay
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO-K1 | IC50 |
10 μM
Compound: 1, 125B11
|
Inhibition of SREBP2 activation expressed in CHO-K1 cells by densitometric analysis
Inhibition of SREBP2 activation expressed in CHO-K1 cells by densitometric analysis
|
[PMID: 21561152] |
| CHO-K1 | IC50 |
5.6 μM
Compound: 1, 125B11
|
Inhibition of SREBP2 activation expressed in CHO-K1 cells co-transfected with pSRE-Luc plasmid assessed as inhibition of luciferase expression after 20 hrs by luciferase reporter gene assay
Inhibition of SREBP2 activation expressed in CHO-K1 cells co-transfected with pSRE-Luc plasmid assessed as inhibition of luciferase expression after 20 hrs by luciferase reporter gene assay
|
[PMID: 21561152] |
Fatostatin (125B11) (0.1-1 μM; 3 days) inhibits the androgen-independent prostate cancer cell proliferation (IC50=0.1 μM) in an independent of the known IGF1-signaling pathway. Fatostatin inhibits insulin-induced adipogenesis of 3T3-L1 cells[1].
Fatostatin directly binds SCAP and blocks its ER-to-Golgi transport with IC50 of 2.5 and 10 μM in mammalian cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:DU-145 cells
-
Concentration:0.1, 1 μM
-
Incubation Time:3 days
-
Result:Impaired the IGF1-induced growth at an IC50 of 0.1 μM.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Four-to-five-week-old homozygous male obese (ob/ob) mice (C57BL/6J)[2]
-
Dosage:30 mg/kg; 150 μL
-
Administration:i.p. injection; daily for 28 days
-
Result:Blocked increases in body weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under uncontrolled food intake.
Chemical Information
-
CAS No. 125256-00-0
-
Appearance Solid
-
Molecular Weight 294.41
-
Formula C18H18N2S
-
Color White to yellow
-
SMILES
CCCC1=NC=CC(C2=NC(C3=CC=C(C)C=C3)=CS2)=C1
-
Synonyms
125B11
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (53)
-
Journal Impact Factor
-
Most Recent
-
Nature
2026 Apr;652(8108):209-219. PMID: 41781621 -
Cancer Cell
2024 Sep 26:S1535-6108(24)00350-7. PMID: 39366375
Fatostatin purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 Sep 26:S1535-6108(24)00350-7. [Abstract]
Representative images of rat mammary organoids treated with Midkine (300 ng/mL), Betulin (5 μM), Fatostatin (5 μM) and Rapamycin (25 nM) for 5 days.
Fatostatin purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 Sep 26:S1535-6108(24)00350-7. [Abstract]
Immunoblot showing the expression of MDK, mature SREBF1 (SREBF1 (M)), S6, p-S6(Ser235/236), AKT, p-AKT(Ser473) in the organoids treated with Midkine (300 ng/mL), Betulin (5 μM), Fatostatin (5 μM) and Rapamycin (25 nM) for 5 days. Tubulin serves as loading control.
-
Cell Metab
TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis. [Abstract]2021 Aug 3;33(8):1655-1670.e8. PMID: 34015269 -
Cell Mol Immunol
YDJC restrains Th1 cell differentiation by blocking SREBP2-mediated cholesterol biosynthesis to alleviate mucosal inflammation in inflammatory bowel disease. [Abstract]2025 Oct 29. PMID: 41162693 -
Nat Commun
The UFL1-AKT positive feedback loop promotes breast cancer progression by enhancing lipid synthesis. [Abstract]2026 Jan 20;17(1):614. PMID: 41559041 -
Nat Commun
Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation. [Abstract]2025 Feb 25;16(1):1774. PMID: 40000627
Fatostatin purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 25;16(1):1774. [Abstract]
Viable cell numbers and PUFA-PC ratio after treatment with LY294002 (iPI3K, 10 µM), Picropodophyllin (iRTK, 10 µM), Ipatasertib (iAkt, 10 µM), or Fatostatin (iSREBP1, 20 µM) for 48 h.
-
Nat Commun
Copy number amplification of FLAD1 promotes the progression of triple-negative breast cancer through lipid metabolism. [Abstract]2025 Feb 1;16(1):1241. PMID: 39890808 -
Cell Death Differ
2021 Jun;28(6):2001-2018. PMID: 33469231 -
Autophagy
Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway. [Abstract]2021 Jul;17(7):1592-1613. PMID: 32432943 -
Adv Sci (Weinh)
Malignant Hepatoblast-Like Cells Sustain Stemness via IGF2-Dependent Cholesterol Accumulation in Hepatoblastoma. [Abstract]2025 Apr 24:e2407671. PMID: 40271711 -
J Clin Invest
ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis. [Abstract]2025 Jul 8:e193134. PMID: 40627441 -
J Exp Clin Cancer Res
The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. [Abstract]2019 May 29;38(1):228. PMID: 31142342 -
Cell Mol Biol Lett
CLDN6 inhibits breast cancer growth and metastasis through SREBP1-mediated RAS palmitoylation. [Abstract]2024 Aug 21;29(1):112. PMID: 39169280 -
Cancer Lett
2024 Jun 18:217068. PMID: 38901665 -
Cell Death Dis
GIPC2 regulation of the PKM2/SREBP1 signaling axis controls adipogenic differentiation of mesenchymal stem cells. [Abstract]2026 Jan 7;17(1):5. PMID: 41500998 -
Cell Death Dis
MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis. [Abstract]2025 May 16;16(1):391. PMID: 40379644 -
Cell Death Dis
MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing. [Abstract]2024 Jun 12;15(6):411. PMID: 38866777 -
Cell Death Dis
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. [Abstract]2021 May 26;12(6):544. PMID: 34039951 -
Cancer Immunol Res
2025 Dec 9. PMID: 41364085 -
Free Radic Biol Med
FATP5 deficiency alleviates MASH via remodeling hepatic lipid composition to suppress ferroptosis. [Abstract]2025 Aug 19:240:170-182. PMID: 40840619 -
NPJ Precis Oncol
SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis. [Abstract]2024 Mar 1;8(1):58. PMID: 38429411 -
Emerg Microbes Infect
SREBP2-dependent lipid droplet formation enhances viral replication and deteriorates lung injury in mice following IAV infection. [Abstract]2025 Dec;14(1):2470371. PMID: 39968754 -
Cell Death Discov
The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis. [Abstract]2022 Oct 28;8(1):431. PMID: 36307402
Fatostatin purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2022 Oct 28;8(1):431. [Abstract]
NUPR1 overexpression‐induced lipogenic enzymes expression can be suppressed by co-incubation with Fatostatin (20 μM; 48 h) in MHCC-97H and SK-Hep1 cells.
Fatostatin purchased from MedChemExpress. Usage Cited in: Cell Death Discov. 2022 Oct 28;8(1):431. [Abstract]
Transwell migration assay. Fatostatin reduces the migration ability of NUPR1-overexpressing MHCC-97H cells.
-
Cell Rep
HSPA8 dampens SCAP/INSIG split and SREBP activation by reducing PKR-mediated INSIG phosphorylation. [Abstract]2025 Feb 19;44(3):115339. PMID: 39977267 -
Cell Rep
Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages. [Abstract]2022 Nov 29;41(9):111738. PMID: 36450259 -
Mol Med
G protein-coupled estrogen receptor activates PI3K/AKT/mTOR signaling to suppress ferroptosis via SREBP1/SCD1-mediated lipogenesis. [Abstract]2024 Feb 21;30(1):28. PMID: 38383297 -
Cell Mol Life Sci
Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation. [Abstract]2025 Jul 3;82(1):270. PMID: 40610622 -
Cell Mol Life Sci
Human cytomegalovirus infection impairs neural differentiation via repressing sterol regulatory element binding protein 2-mediated cholesterol biosynthesis. [Abstract]2024 Jul 6;81(1):289. PMID: 38970696 -
Cell Biosci
Gut microbial metabolite deoxycholic acid facilitates Th17 differentiation through modulating cholesterol biosynthesis and participates in high-fat diet-associated colonic inflammation. [Abstract]2023 Oct 3;13(1):186. PMID: 37789469 -
JCI Insight
Regulatory T-cell and neutrophil extracellular traps interaction contributes to the development of immunosuppression in sepsis. [Abstract]2024 Jun 18:e180132. PMID: 38888975 -
J Ethnopharmacol
Paris polyphylla Smith var. yunnanensis-derived saponins potentiate the antitumor activity of GPX4 inhibitors. [Abstract]2026 Feb 28:357:120890. PMID: 41232632 -
J Ethnopharmacol
Corydalis saxicola Bunting total alkaloids improve NAFLD by suppressing de novo lipogenesis through the AMPK-SREBP1 axis. [Abstract]2024 Jan 30;319(Pt 1):117162. PMID: 37690477 -
J Pathol
ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p. [Abstract]2020 Dec;252(4):358-370. PMID: 32770671 -
Eur J Pharmacol
Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression. [Abstract]2025 Sep 15:1003:177890. PMID: 40617382 -
Int Immunopharmacol
Alcohol intake exacerbates experimental autoimmune prostatitis through gut microbiota driving cholesterol biosynthesis-mediated Th17 differentiation. [Abstract]2024 Jul 18:139:112669. PMID: 39029231 -
Mol Oncol
Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesis. [Abstract]2025 Jun;19(6):1668-1686. PMID: 39425259 -
Cancers (Basel)
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters. [Abstract]2023 Jun 3;15(11):3043. PMID: 37297005 -
J Cell Mol Med
2025 Jul;29(14):e70710. PMID: 40682485 -
iScience
Influenza A virus infection activates STAT3 to enhance SREBP2 expression, cholesterol biosynthesis, and virus replication. [Abstract]2024 Jun 29;27(8):110424. PMID: 39108727 -
Oncol Rep
Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma. [Abstract]2018 Apr;39(4):1919-1929. PMID: 29436682 -
Biochim Biophys Acta Mol Cell Biol Lipids
Tumor necrosis factor alpha-induced activation of SREBP2 promotes cholesterol biosynthesis in cholestasis. [Abstract]2025 Jun 6:159642. PMID: 40484275 -
Mol Carcinog
LATS-regulated nuclear-cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial-mesenchymal transition. [Abstract]2023 Jul;62(7):963-974. PMID: 37042569 -
Br J Nutr
Dietary palm oil enhances SREBP2-mediated cholesterol biosynthesis through inducing endoplasmic reticulum stress in muscle of large yellow croaker ( Larimichthys crocea). [Abstract]2024 Feb 28;131(4):553-566. PMID: 37699661 -
Anal Cell Pathol
Identification of the Antioxidant Enzyme B166 as a Novel Biomarker for Patients With Glioblastoma Multiforme. [Abstract]2026;2026(1):e6120748. PMID: 41810932 -
Exp Eye Res
SREBP1-driven SCD1 protects retinal pigment epithelium from oxidative damage by activating the NRF2/GPX4 axis. [Abstract]2026 May:266:110932. PMID: 41720386 -
Exp Eye Res
SREBF1 facilitates pathological retinal neovascularization by reprogramming the fatty acid metabolism of endothelial cells. [Abstract]2025 Jan 10:110239. PMID: 39800283 -
Tissue Cell
Intracellullar cholesterol accumulation caused by HBV induces ATF6-mediated endoplasmic reticulum stress to trigger endoplasmic reticulophagy. [Abstract]2025 Sep 9:98:103134. PMID: 40934546 -
Oncol Lett
SREBP1 silencing inhibits the proliferation and motility of human esophageal squamous carcinoma cells via the Wnt/β-catenin signaling pathway. [Abstract]2020 Sep;20(3):2855-2869. PMID: 32765792 -
Biol Pharm Bull
Inhibition of Stearoyl-CoA Desaturase 1 Potentiates Anti-tumor Activity of Amodiaquine in Non-small Cell Lung Cancer. [Abstract]2022 Apr 1;45(4):438-445. PMID: 35110426 -
-
-
-
Solvent & Solubility
DMSO : ≥ 27 mg/mL (91.71 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (8.49 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 2.5 mg/mL (8.49 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: Corn Oil
Solubility: 5 mg/mL (16.98 mM); Suspended solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Choi Y, et al. Identification of bioactive molecules by adipogenesis profiling of organic compounds. J Biol Chem. 2003 Feb 28;278(9):7320-4. [Content Brief]
[2]. Kamisuki S, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009 Aug 28;16(8):882-92. [Content Brief]
[3]. Li X et al. Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling. Mol Cancer Ther. 2014 Apr;13(4):855-66. [Content Brief]
[4]. Shao W et al. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. J Lipid Res. 2016 Aug;57(8):1564-73. [Content Brief]
[5]. Inoue K et al. Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation. Biochim Biophys Acta. 2015 Nov;1852(11):2432-41. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.3966 mL | 16.9831 mL | 33.9662 mL | 84.9156 mL |
| 5 mM | 0.6793 mL | 3.3966 mL | 6.7932 mL | 16.9831 mL | |
| 10 mM | 0.3397 mL | 1.6983 mL | 3.3966 mL | 8.4916 mL | |
| 15 mM | 0.2264 mL | 1.1322 mL | 2.2644 mL | 5.6610 mL | |
| 20 mM | 0.1698 mL | 0.8492 mL | 1.6983 mL | 4.2458 mL | |
| 25 mM | 0.1359 mL | 0.6793 mL | 1.3586 mL | 3.3966 mL | |
| 30 mM | 0.1132 mL | 0.5661 mL | 1.1322 mL | 2.8305 mL | |
| 40 mM | 0.0849 mL | 0.4246 mL | 0.8492 mL | 2.1229 mL | |
| 50 mM | 0.0679 mL | 0.3397 mL | 0.6793 mL | 1.6983 mL | |
| 60 mM | 0.0566 mL | 0.2831 mL | 0.5661 mL | 1.4153 mL | |
| 80 mM | 0.0425 mL | 0.2123 mL | 0.4246 mL | 1.0614 mL |